vimarsana.com

சூரியன் மருந்து தொழில்கள் இன்க் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Orexo Claims Competitor Infringed Its Pharmaceutical Patents for Opioid Dependency Medication

Health your username 11 hours ago Orexo AB and Orexo US, Inc filed a lawsuit against Sun Pharmaceutical Industries Limited, Sun Pharma Global FZE, and Sun Pharmaceutical Industries, Inc. alleging the company infringed its patents for Zubsolv, a drug designed to treat opioid dependency.  The lawsuit, which was filed last Friday in the District of New Jersey, follows Sun’s filing of an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA). The plaintiffs claimed that Sun is seeking approval to produce and market a generic version of their medication, Zubsolv, prior to the expiration of the patents protecting it.

Lupin, Sun Pharma and Jubilant Cadista recall drugs in US market

Lupin, Sun Pharma and Jubilant Cadista recall drugs in US market A class II recall is initiated in a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences Leading generic drug makers Lupin, Sun Pharma and Jubilant Cadista are recalling different products in the US, the world’s largest market for medicines, for different reasons. According to the latest enforcement report by the US Food and Drug Administration (USFDA), the US-based unit of Lupin is recalling 17,814 bottles of Cefprozil for Oral Suspension USP, a second-generation antibiotic used to treat infections of the ear, skin and other bacterial infections.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.